U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Analyst Upgrades and Downgrades
Separately, TheStreet raised shares of U.S. Physical Therapy from a "c+" rating to a "b-" rating in a research report on Thursday, July 28th.
U.S. Physical Therapy Price Performance
NYSE:USPH opened at $89.04 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.08 and a current ratio of 1.43. The stock has a market cap of $1.16 billion, a price-to-earnings ratio of 30.39 and a beta of 1.22. The business has a 50 day simple moving average of $112.50 and a 200 day simple moving average of $104.68. U.S. Physical Therapy has a 52-week low of $84.43 and a 52-week high of $131.50.
U.S. Physical Therapy (NYSE:USPH - Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.93 by ($0.03). The company had revenue of $140.70 million for the quarter, compared to the consensus estimate of $143.01 million. U.S. Physical Therapy had a return on equity of 14.22% and a net margin of 7.62%. The firm's revenue was up 10.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.96 EPS. Analysts anticipate that U.S. Physical Therapy will post 2.7 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 16th. Stockholders of record on Thursday, August 18th will be given a dividend of $0.41 per share. The ex-dividend date is Wednesday, August 17th. This represents a $1.64 annualized dividend and a dividend yield of 1.84%. U.S. Physical Therapy's dividend payout ratio is currently 55.97%.
Insider Transactions at U.S. Physical Therapy
In other news, Director Anne Motsenbocker bought 500 shares of the business's stock in a transaction on Tuesday, August 9th. The shares were purchased at an average price of $92.29 per share, for a total transaction of $46,145.00. Following the purchase, the director now owns 2,600 shares of the company's stock, valued at approximately $239,954. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 3,818 shares of the business's stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $92.24, for a total transaction of $352,172.32. Following the sale, the chief operating officer now directly owns 16,191 shares of the company's stock, valued at approximately $1,493,457.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Anne Motsenbocker acquired 500 shares of the firm's stock in a transaction dated Tuesday, August 9th. The stock was bought at an average price of $92.29 per share, with a total value of $46,145.00. Following the acquisition, the director now directly owns 2,600 shares in the company, valued at $239,954. The disclosure for this purchase can be found here. 1.90% of the stock is owned by insiders.